Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
mBio. 2011 Mar 1;2(2):e00271-10. doi: 10.1128/mBio.00271-10. Print 2011.
The gut microbiota enhances the host's metabolic capacity for processing nutrients and drugs and modulate the activities of multiple pathways in a variety of organ systems. We have probed the systemic metabolic adaptation to gut colonization for 20 days following exposure of axenic mice (n = 35) to a typical environmental microbial background using high-resolution (1)H nuclear magnetic resonance (NMR) spectroscopy to analyze urine, plasma, liver, kidney, and colon (5 time points) metabolic profiles. Acquisition of the gut microbiota was associated with rapid increase in body weight (4%) over the first 5 days of colonization with parallel changes in multiple pathways in all compartments analyzed. The colonization process stimulated glycogenesis in the liver prior to triggering increases in hepatic triglyceride synthesis. These changes were associated with modifications of hepatic Cyp8b1 expression and the subsequent alteration of bile acid metabolites, including taurocholate and tauromuricholate, which are essential regulators of lipid absorption. Expression and activity of major drug-metabolizing enzymes (Cyp3a11 and Cyp2c29) were also significantly stimulated. Remarkably, statistical modeling of the interactions between hepatic metabolic profiles and microbial composition analyzed by 16S rRNA gene pyrosequencing revealed strong associations of the Coriobacteriaceae family with both the hepatic triglyceride, glucose, and glycogen levels and the metabolism of xenobiotics. These data demonstrate the importance of microbial activity in metabolic phenotype development, indicating that microbiota manipulation is a useful tool for beneficially modulating xenobiotic metabolism and pharmacokinetics in personalized health care.
Gut bacteria have been associated with various essential biological functions in humans such as energy harvest and regulation of blood pressure. Furthermore, gut microbial colonization occurs after birth in parallel with other critical processes such as immune and cognitive development. Thus, it is essential to understand the bidirectional interaction between the host metabolism and its symbionts. Here, we describe the first evidence of an in vivo association between a family of bacteria and hepatic lipid metabolism. These results provide new insights into the fundamental mechanisms that regulate host-gut microbiota interactions and are thus of wide interest to microbiological, nutrition, metabolic, systems biology, and pharmaceutical research communities. This work will also contribute to developing novel strategies in the alteration of host-gut microbiota relationships which can in turn beneficially modulate the host metabolism.
肠道微生物群增强了宿主处理营养物质和药物的代谢能力,并调节了多种器官系统中多种途径的活性。我们使用高分辨率(1)H 核磁共振(NMR)光谱法分析尿液、血浆、肝脏、肾脏和结肠(5 个时间点)的代谢谱,研究了无菌小鼠(n = 35)暴露于典型环境微生物背景后 20 天内对肠道定植的全身代谢适应性。肠道微生物群的获得与定植后前 5 天体重的快速增加(4%)有关,所有分析的隔室中都平行地改变了多种途径。定植过程刺激了肝脏中的糖生成,然后触发了肝内三酰甘油合成的增加。这些变化与 Cyp8b1 表达的改变以及随后胆汁酸代谢物(包括牛磺胆酸盐和牛磺熊去氧胆酸盐)的改变有关,这些代谢物是脂质吸收的重要调节剂。主要药物代谢酶(Cyp3a11 和 Cyp2c29)的表达和活性也显著受到刺激。值得注意的是,通过 16S rRNA 基因焦磷酸测序分析的肝代谢谱与微生物组成之间相互作用的统计模型揭示了 Coriobacteriaceae 家族与肝三酰甘油、葡萄糖和肝糖原水平以及外源性物质代谢之间存在强烈关联。这些数据表明微生物活性在代谢表型发育中的重要性,表明微生物操纵是一种有益的调节方法,可用于个性化医疗中外源性物质代谢和药代动力学。
肠道细菌与人类的各种基本生物学功能有关,例如能量收获和血压调节。此外,肠道微生物定植发生在出生后与其他关键过程(如免疫和认知发育)同时进行。因此,了解宿主代谢与其共生体之间的双向相互作用至关重要。在这里,我们描述了宿主和肠道微生物群之间的第一个体内关联的证据。这些结果为调节宿主-肠道微生物群相互作用的基本机制提供了新的见解,因此受到微生物学、营养、代谢、系统生物学和制药研究界的广泛关注。这项工作还将有助于开发改变宿主-肠道微生物群关系的新策略,从而可以有益地调节宿主代谢。